Technology News and Research

RSS

Alnylam announces new pre-clinical results with DC for ALN-CC5 to treat complement-mediated diseases

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today new pre-clinical results with its Development Candidate (DC) for ALN-CC5, a subcutaneously administered investigational RNAi therapeutic targeting complement component C5 in development for the treatment of complement-mediated diseases.

10 Jun 2014

Liquid Grids launches new Software as a Service platform for healthcare industry

Liquid Grids®, a precision marketing platform for the healthcare industry, announces the launch of its new Software as a Service (SaaS) platform specifically designed for the healthcare industry.

10 Jun 2014

Celsion signs definitive asset purchase agreement to acquire EGEN

Celsion Corporation (Celsion) (NASDAQ: CLSN), an oncology drug development company, and EGEN, Inc. (EGEN), a privately-held biopharmaceutical company focused on the development of nucleic acid-based therapeutics for the treatment of cancer and other difficult to treat diseases, today announced the signing of a definitive asset purchase agreement in which Celsion will acquire substantially all of the assets of EGEN, including its Phase Ib DNA-based immunotherapy product candidate EGEN-001 and its therapeutic platform technologies, TheraPlas™ for delivery of DNA and mRNA, TheraSilence™ for delivery of RNA, and RAST™ for Cell Enabled Expression and Secretion of RNA.

10 Jun 2014

Viewpoints: 'Triage' at the VA; GOP can't 'fix' health law; mental health problems in LA jail

Washington's attention span on the Veterans Affairs scandal seems to be expiring. Though 42 of the VA's 152 major campuses (27%) are still under investigation for falsifying wait-time records, the Senate is converging on a bipartisan deal that claims to solve the problem.

10 Jun 2014

Pulsar Vascular announces FDA approval of PulseRider IDE for intracranial bifurcation aneurysms

Pulsar Vascular, the innovator and developer of the PulseRider, a minimally invasive, aneurysm neck reconstruction device, announced today the United States Food and Drug Administration's approval of an Investigational Device Exemption (IDE) for the PulseRider.

10 Jun 2014

Synthetic, Enterome partner to study effects of beta-lactam antibiotics on gastrointestinal microflora

Synthetic Biologics, Inc., a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, and Enterome Bioscience SA, a pioneer in the development of innovative disease management solutions based on a deep understanding of the gut microbiome, today announced that they have entered into an agreement to conduct metagenomic research on the effects of beta-lactam antibiotics on the gastrointestinal microflora (microbiome) of human patients.

10 Jun 2014

New innovative body suit improves horse riders’ balance, symmetry, poor posture

HORSE riders' balance, symmetry and poor posture could be improved thanks to an innovative body suit that works with motion sensors, commonly used by movie makers and the video games industry.

10 Jun 2014

Findings add surprising new dimension to understanding of antibody repertoires

As elite soldiers of the body's immune response, B cells serve as a vast standing army ready to recognize and destroy invading antigens, including infections and cancer cells. To do so, each new B cell comes equipped with its own highly specialized weapon, a unique antibody protein that selectively binds to specific parts of the antigen.

10 Jun 2014

State highlights: Improving chronic care in Las Vegas; standoff over Medicaid in N.C.

Now, Las Vegas is emerging as a test of how much a community can improve chronically poor health by expanding insurance coverage and using models of medical care pioneered in healthier places. "We are a prime example of what people see as problematic about the American healthcare system," said Larry Matheis, the former longtime head of the Nevada State Medical Assn. "That makes a lot of the ideas in health reform very attractive. … The challenge is going to be figuring out how to make it all work" (Levey, 6/7).

10 Jun 2014

Text4baby benefits pregnant women

The leading mobile health service in the nation, Text4baby, was found to significantly benefit pregnant women, according to a new study led by Milken Institute School of Public Health (Milken Institute SPH) at the George Washington University and the Madigan Army Medical Center.

10 Jun 2014

CSMG and CSHA groups awarded highest designation for quality care

For the fifth year in a row, Cedars-Sinai Medical Group and Cedars-Sinai Health Associates have been awarded the highest possible designation for quality care by a leading national organization representing managed care physician groups. CAPG, formerly known as the California Association of Physician Groups, rated both Cedars-Sinai groups as excelling in all six of the criteria used in the 2014 Standards of Excellence survey.

10 Jun 2014

New technology improves quality of life for kids with severe developmental disabilities

A group of Kansas State University engineers and students is developing technology to improve the health and quality of life for children with severe developmental disabilities.

10 Jun 2014

Penn researchers awarded $10 million grant to study adverse health effects, remediation of asbestos

Researchers at the Center of Excellence in Environmental Toxicology, Perelman School of Medicine at the University of Pennsylvania, have been awarded a $10 million grant from the National Institute for Environmental Health Sciences over the next four years to study asbestos exposure pathways that lead to mesothelioma, the bioremediation of this hazardous material, and mechanisms that lead to asbestos-related diseases.

10 Jun 2014

Contacta to manufacture HLD large area hearing loop product platform in the USA

Contacta Inc. has today announced the HLD large area hearing loop product platform will be manufactured in the USA.

9 Jun 2014

Isis Pharmaceuticals begins ISIS-DMPK Rx Phase 1 study for treatment of Myotonic Dystrophy Type 1

Isis Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 study for ISIS-DMPKRx. Isis earned a $14 million milestone payment from Biogen Idec associated with this achievement.

9 Jun 2014

Naval leaders, small business representatives converge at Navy Opportunity Forum

Top naval leaders met with representatives from some of the nation's most cutting-edge small businesses this week at the Navy Opportunity Forum in Crystal City, Va., with the goal of discovering new technologies and capabilities for America's Sailors and Marines.

9 Jun 2014

University of Indianapolis breaks ground June 19 on $28 million Health Pavilion

The University of Indianapolis will break ground June 19 on a four-story, $28 million Health Pavilion that will house UIndy's healthcare- and wellness-related academic programs as well as industry partners and clinical facilities to serve the community.

9 Jun 2014

Toshiba provides new PET/CT system for radiation and oncology imaging needs

Oncology departments can now provide their patients with a better PET/CT imaging experience using Toshiba America Medical Systems, Inc.'s all-new Celesteion (pending 510(k) clearance).

9 Jun 2014

BioDelivery Sciences receives approval of NDA for BUNAVAIL from FDA

BioDelivery Sciences International, Inc. received approval of the New Drug Application (NDA) for BUNAVAIL™ (buprenorphine and naloxone) buccal film (CIII) from the U.S. Food and Drug Administration (FDA).

9 Jun 2014

Rubicon signs agreements with 7 distributors to expand availability of DNA library preparation products

Rubicon Genomics, Inc., today announced that it signed agreements with seven distributors in Europe to expand the availability of its leading DNA library preparation products, including ThruPLEX®-FD Prep Kit and PicoPLEX™ DNA-seq Kit for use with Illumina® next-generation sequencing (NGS) systems and PicoPLEX™ WGA Kit for use on arrays, and to prepare for new product launches planned for the coming months.

9 Jun 2014

Technology News and Research

Alnylam announces new pre-clinical results with DC for ALN-CC5 to treat complement-mediated diseases

Liquid Grids launches new Software as a Service platform for healthcare industry

Celsion signs definitive asset purchase agreement to acquire EGEN

Viewpoints: 'Triage' at the VA; GOP can't 'fix' health law; mental health problems in LA jail

Pulsar Vascular announces FDA approval of PulseRider IDE for intracranial bifurcation aneurysms

Synthetic, Enterome partner to study effects of beta-lactam antibiotics on gastrointestinal microflora

New innovative body suit improves horse riders’ balance, symmetry, poor posture

Findings add surprising new dimension to understanding of antibody repertoires

State highlights: Improving chronic care in Las Vegas; standoff over Medicaid in N.C.

Text4baby benefits pregnant women

CSMG and CSHA groups awarded highest designation for quality care

New technology improves quality of life for kids with severe developmental disabilities

Penn researchers awarded $10 million grant to study adverse health effects, remediation of asbestos

Contacta to manufacture HLD large area hearing loop product platform in the USA

Isis Pharmaceuticals begins ISIS-DMPK Rx Phase 1 study for treatment of Myotonic Dystrophy Type 1

Naval leaders, small business representatives converge at Navy Opportunity Forum

University of Indianapolis breaks ground June 19 on $28 million Health Pavilion

Toshiba provides new PET/CT system for radiation and oncology imaging needs

BioDelivery Sciences receives approval of NDA for BUNAVAIL from FDA

Rubicon signs agreements with 7 distributors to expand availability of DNA library preparation products

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News